Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics 
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Australia
Tocris Bioscience Distributor Network
Tocris Bioscience products are available for sale from the distributor(s) listed below. Please contact the distributor directly for pricing, shipping information and technical support.
| Bio-Scientific Pty. Ltd. | |
| P.O. Box 78 | |
| Gymea 2227 N.S.W. | |
| Australia | |
| Phone: | +61 2 9521 2177 |
| Fax: | +61 2 9542 3100 |
| Email: | info@biosci.com.au |
| Web: | www.biosci.com.au |
| Sapphire Bioscience Pty. Ltd. | |
| 126 Cope Street | |
| Waterloo NSW 2017 | |
| Australia | |
| Phone: | +61 2 9698 2022 |
| Fax: | +61 2 9698 1022 |
| Email: | sales@sapphirebioscience.com |
| Web: | www.sapphirebioscience.com |
| Abacus ALS | |
| PO Box 7183 | |
| East Brisbane | |
| QLD 4169 | |
| Australia | |
| Phone: | +61 7 3391 9777 |
| Phone: | 1800 222 287 (Toll Free) |
| Fax: | +61 7 3391 9799 |
| Email: | info@abacus-als.com |
| Web: | www.abacus-als.com |
View all countries served by the official Tocris distributors.
Quick Order
Find multiple products by catalog number
New Product E-alerts
Sign up for email updates from Tocris
20% Discount*
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.